Navigation Links
Immune system assassin's tricks visualised for the first time
Date:10/31/2010

a hole-punching machine."

The structure was revealed by combining information about a single perforin molecule visualised using the Australian Synchrotron with Professor Saibil's electron microscope images, (taken in London), of a ring of perforin molecules clustered together to form a hole in a cell membrane.

Professor Whisstock added "Now we know how it works, we can start to fine tune it to fight cancer, malaria and diabetes."

Another interesting finding is that the important parts of the perforin molecule are quite similar to those toxins deployed by bacteria such as anthrax, listeria and streptococcus, showing that this method of making holes in cell membranes is quite ancient in evolution. "The molecular structure has survived for close to two billion years, we think," said Professor Trapani.

Perforin is also the culprit when the wrong cells are marked for elimination, either in autoimmune disease conditions, such as early onset diabetes, or in tissue rejection following bone marrow transplantation. So the researchers are now investigating ways to boost perforin for more effective cancer protection and therapy for acute diseases such as cerebral malaria. And with the help of a 600K grant from the Wellcome Trust they are working on potential inhibitors to suppress perforin and counter tissue rejection.

Professor Douglas Kell, BBSRC Chief Executive said "New technologies in microscopy and synchrotron experiments have opened up tremendous opportunities for molecular biologists. This is a great example where the knowledge we gain about the normal structure and function of a molecule has the potential to underpin important developments in our health and well being."


'/>"/>

Contact: Nancy Mendoza
press.office@bbsrc.ac.uk
0044-179-341-3355
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Page: 1 2

Related biology news :

1. Penn study shows 2-sided immune cell could be harnessed to shrink tumors
2. Novel regulatory process for T cells may help explain immune system diseases
3. Shifting forms: Penn study shows how variations of same protein affect immune response
4. How immune response in pregnancy may lead to brain dysfunction in offspring
5. Studying illnesses caused by worms: Scientists are learning how immune cells communicate
6. Hormone acting as molecular glue could boost plant immune systems
7. Discovery of a cell that suppresses the immune system
8. CRISPR critters: Scientists identify key enzyme in microbial immune system
9. Microfluidic device allows collection, analysis of hard-to-handle immune cells
10. ISU researchers discover cause of immune system avoidance of certain pathogens
11. Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... Calif. , June 24, 2015  Synaptics ... of human interface solutions, today announced that Sharp ... to provide secure authentication for its latest flagship ... reached more than 200 million shipments of its ... Sharp reinforces Synaptics, strength, scalability and leadership in ...
(Date:6/24/2015)... , June 24, 2015 Biometry authentication ... emerging biometric password solution one face in. ... one face in, entering the expanding ... and affordable multifactor-authentication biometric answer to the password ... provided in partnership with KeyLemon, one face in ...
(Date:6/23/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Body-Worn ... Share, Growth, Trends and Forecast 2014 - 2020" ... report offers strategic analysis of the global body-worn ... market has been segmented on the basis of ...
Breaking Biology News(10 mins):Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... Inc., a Detroit-based company, announced that it has received ... Mich. NextCAT is commercializing biodiesel catalyst technology developed at ... that will allow biodiesel producers to use cost-effective raw ... class of catalysts that enable producers to use a ...
... plants, often illegally, and moving them outside their native range, ... by Patrick Shirey and Gary Lamberti in the department of ... to their research last year, nearly 10 percent of the ... Endangered Species Act are being sold or, at least, ...
... Ill. When it comes to breaking down plant matter ... figured out. Its digestive system allows it to eat more ... report that they have found dozens of previously unknown microbial ... chamber that contribute to the breakdown of switchgrass, a ...
Cached Biology News:Notre Dame biologists call for regulation of rare plant sales 2Team looks to the cow rumen for better biofuels enzymes 2Team looks to the cow rumen for better biofuels enzymes 3
(Date:7/6/2015)... ANGELES , July 6, 2015 ImmunoCellular ... establishment of an agreement with Novella Clinical ... ICT-107 in patients with newly diagnosed glioblastoma. Novella is ... trial services to small to mid-sized oncology companies. The ... sites in the US, Europe ...
(Date:7/3/2015)... , July 3, 2015 /PRNewswire/ ... hakea verkossa osoitteessa  http://www.openinnovationinscience.at ... Innovation in Science" -jatkokoulutusohjelmaan 22.7.2015 ... Gesellschaftin (LBG) tekemän, kansainvälisiä tutkijoita ... terveystieteiden kaksi suurinta haastetta ovat ...
(Date:7/3/2015)... 3, 2015 Forskare ... 2015 på  http://www.openinnovationinscience.at till det återkommande ... som hålls i Wien ... med internationella forskare och vetenskapsmän som genomfördes ... två största utmaningar bristen på incitament för ...
(Date:7/3/2015)... , July 3, 2015 ... 22. september 2015 på  http://www.openinnovationinscience.at om ... der finder sted i Wien ... undersøgelse af internationale forskere og videnskabsmænd foretaget ... to største udfordringer for sundhedsvidenskaben manglen på ...
Breaking Biology Technology:ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Lansering av världens första program för öppen innovation för att utbilda forskare 2Lansering av världens första program för öppen innovation för att utbilda forskare 3Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 2Lancering af verdens første åbne innovationsprogram til uddannelse af forskere 3
... to Feature ,Kidney-Friendly, Recipes, HOUSTON, Dec. 7 ... (Nasdaq: SHPGY ), the global biopharmaceutical,company, today ... cooking,demonstration at the Doubletree Hotel Houston Downtown from ... with chronic kidney,disease (CKD) and their families., ...
... Fla., Dec. 7 Tutogen Medical, Inc.,(Amex: TTG ... from human (allograft) and animal (xenograft) tissue, will report,financial ... 30, 2007 on Monday, December 10, 2007 at 4:30 ... by dialing (888) 408-9532 or,(706) 679-5064 or by accessing ...
... a Select Group in North America with this Elevated Partner ... ... BIAS Corporation, an Oracle System,Integrator, today announced it has achieved Oracle Certified ... - - the highest level in the Oracle PartnerNetwork -- BIAS had,to ...
Cached Biology Technology:Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 2Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 3Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 4Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 5Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 6Katie Lee Joel to Conduct Free, Hands-On, Holiday Cooking Demonstration for Local Patients With Chronic Kidney Disease 7Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results 2BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork 2BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork 3
Quinolinate phosphoribosyltransferase...
ICC Diluent Buffer 250 ml...
This antibody is specific for human J-chain as defined by ELISA assay using purified human immunoglobulin fragments as solid phase target antigen....
...
Biology Products: